DSM

Enable Injections Appoints David Kroekel as Chief Operating Officer

Retrieved on: 
Wednesday, February 7, 2024
Senior, Teleflex, DSM, Engineering, Mechanical, Patient, FDA, Enabling, Injection, Pennsylvania State University, Lehigh University, Enblend, U.S. FDA, Pharmaceutical industry

CINCINNATI, Feb. 7, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery systems, today announced the appointment of David Kroekel, previously Senior Vice President, Product Development and Operations at Enable, to Chief Operating Officer. In this critical position, Mr. Kroekel will play an important role leading the ongoing engineering, manufacturing, and supply of the Company's enFuse technology.

Key Points: 
  • CINCINNATI, Feb. 7, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery systems, today announced the appointment of David Kroekel, previously Senior Vice President, Product Development and Operations at Enable, to Chief Operating Officer.
  • In this critical position, Mr. Kroekel will play an important role leading the ongoing engineering, manufacturing, and supply of the Company's enFuse technology.
  • "David brings a wealth of experience in cross-functional collaboration, infrastructure development, and engineering excellence in medical device manufacturing and development," said Mike Hooven, Chairman and CEO of Enable Injections.
  • I look forward to leading and advancing how our manufacturing and product development teams increase the capabilities and efficiencies in delivering our wearable technology to more patients," said David Kroekel, Chief Operating Officer of Enable Injections.

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

Retrieved on: 
Monday, January 29, 2024
Info, Sleep, Patient, PAP, Sleep apnea, Medicare, DDS, Food and Drug Administration, ASBA, Respironics, Obstructive sleep apnea, Food, CPAP, DSM, FDA, Paps, News, Diagnosis, OAT, Physician, Pharmaceutical industry

PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is well-positioned to support patients with OSA and sleep physicians who can no longer access discontinued OSA devices.

Key Points: 
  • PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is well-positioned to support patients with OSA and sleep physicians who can no longer access discontinued OSA devices.
  • Earlier in January, Philips Respironics announced the discontinuation of many devices used for the treatment and diagnosis of sleep apnea, including CPAP systems.
  • “Scientific data from over a dozen studies, including hundreds of patients, establish ProSomnus devices as safe, effective, and patient preferred.
  • “Philips has been a prominent player in the sleep health industry, providing innovative solutions for sleep apnea and other sleep disorders.

Fortanix Data Security Manager (DSM) SaaS Now Available in AWS Marketplace

Retrieved on: 
Thursday, January 18, 2024
Data Management, Security, Technology, Software, Networks, Internet, Cloud, Privacy, Confidentiality, GDPR, Glass, Software as a service, Amazon Web Services, HSM, Organization, Computer security, DSM, AWS, XKS, Government, Key, FIPS, Cryptocurrency

Fortanix DSM is a unified data-first security platform that protects sensitive data across AWS, hybrid, and private cloud environments from a single pane of glass.

Key Points: 
  • Fortanix DSM is a unified data-first security platform that protects sensitive data across AWS, hybrid, and private cloud environments from a single pane of glass.
  • Fortanix DSM SaaS on AWS is the solution for data security, compliance protection, and responsible handling of privacy information in today's digital landscape.
  • “We're thrilled to bring Fortanix DSM to AWS Marketplace,” said Iulia Stefoi-Silver, VP, Alliances at Fortanix.
  • The availability of Fortanix DSM in AWS Marketplace brings a reliable Key Management System as a Service that integrates with AWS Key Management Service (AWS KMS) External Key Store (XKS), providing AWS customers with an additional way to align with data privacy regulations, maintain compliance and data control requirements, and fulfil data protection initiatives.”
    Fortanix DSM is available in AWS Marketplace as cloud-based software sales skyrocket.

Wes Wheeler Assumes Role as Executive Chair of the Board at BioTouch™

Retrieved on: 
Thursday, January 18, 2024
ASC, GSK, Chair, DSM, Kuehne + Nagel, GSK plc, HAVEN, Growth, Management

"Wes Wheeler brings a proven leadership style and strategic vision to his role, having previously held key positions in various healthcare organizations.

Key Points: 
  • "Wes Wheeler brings a proven leadership style and strategic vision to his role, having previously held key positions in various healthcare organizations.
  • With a career spanning more than two decades, Wes Wheeler has held the positions of CEO, President, and Chair across five distinct public and private companies including UPS Healthcare, Marken, Patheon (a ThermoFisher company), Bushu, and DSM.
  • In a recent statement, Wheeler expressed his enthusiasm about assuming the role of Executive Chair of the Board for BioTouch.
  • Robert Coyle expressed his enthusiasm about Wes Wheeler's appointment as Executive Chair of the Board, stating, "We are thrilled to welcome Wes to BioTouch as our new Executive Chair.

Chase Plastics is authorized distributor for newly formed Envalior

Retrieved on: 
Tuesday, January 16, 2024
Alloy, Partnership, LANXESS, DSM, Plastic, PBT, Engineering

CLARKSTON, Mich., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Chase Plastics announced today that they are an authorized distributor for the new global engineering materials entity, Envalior. Formed last year, Envalior brings together two established global material players − DSM Engineering Materials and LANXESS High Performance Materials − and a combined heritage of over 100 years.

Key Points: 
  • Chase Plastics announced today that they are an authorized distributor for the new global engineering materials entity.
  • CLARKSTON, Mich., Jan. 16, 2024 /PRNewswire-PRWeb/ -- Chase Plastics announced today that they are an authorized distributor for the new global engineering materials entity, Envalior.
  • "Chase Plastics is a great fit for Envalior, and we are proud to have them as a distribution partner," said Grace Showalter, Envalior Regional Commercial Director - Americas.
  • Chase Plastics is authorized to distribute Envalior's full line of products, including STANYL®: PA46, POCAN®: PBT, PBT alloys, and AKULON®: PA6 & 66.

dsm-firmenich makes voluntary cash offer for DSM shares

Retrieved on: 
Monday, January 8, 2024
AMRO Bank, ABN AMRO, ABN, DSM, Enterprise, Euronext Amsterdam

KAISERAUGST, Switzerland and HEERLEN, Netherlands, Jan. 8, 2024 /PRNewswire/ -- DSM-Firmenich AG (the Company or dsm-firmenich) and DSM B.V. (DSM) today announce that the remaining holders of DSM ordinary shares will have the opportunity to sell their DSM ordinary shares to dsm-firmenich through the voluntary tender offer launched by dsm-firmenich today.

Key Points: 
  • KAISERAUGST, Switzerland and HEERLEN, Netherlands, Jan. 8, 2024 /PRNewswire/ -- DSM-Firmenich AG (the Company or dsm-firmenich) and DSM B.V. (DSM) today announce that the remaining holders of DSM ordinary shares will have the opportunity to sell their DSM ordinary shares to dsm-firmenich through the voluntary tender offer launched by dsm-firmenich today.
  • dsm-firmenich started a statutory buy-out procedure (the Buy-Out) on July 17, 2023 to acquire the remaining ordinary shares, about 3.9%, in DSM, previously Koninklijke DSM N.V. (the Shares).
  • The Company offers the remaining holders of the Shares the opportunity to sell their Shares at an offer price of €96.00 (the Offer Price).
  • Remaining holders of the Shares who have sold and transferred their Shares for acceptance in the Voluntary Tender Offer will receive the Offer Price for their sold Shares on February 13, 2024.

Deep-South Completes Name Change to Koryx Copper Inc.

Retrieved on: 
Friday, November 10, 2023
Courage, ISIN, KRY, DSM, CUSIP, Oryx, Deep South

VANCOUVER, British Columbia, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Deep-South Resources Inc. ("Deep-South" or “the Company") (TSX-V: DSM) announces the successful completion of its name and symbol change.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Deep-South Resources Inc. ("Deep-South" or “the Company") (TSX-V: DSM) announces the successful completion of its name and symbol change.
  • The Company’s new trading symbol will be KRY and its CUSIP number will be 50067J103 and its new ISIN number is CA50067J1030.
  • There is no change in the share capital of the Company and no action is required to be taken by the Company’s shareholders with respect to this corporate name change.
  • We have decided to change the name to offer a better representativity of our core values.

Lack of Encryption the Primary Reason for Sensitive Data Loss

Retrieved on: 
Friday, December 8, 2023
Data Management, Security, Technology, Software, Networks, Internet, Policy, Organization, Confidentiality, Risk, Rest, DevOps, PQC, DSM, Confusion, Motion, Overalls, Education, ESG, Online shopping, Cryptocurrency, Risk management

Fortanix® Inc. , a leader in data security and pioneer of Confidential Computing , today revealed the results of a new study conducted by Enterprise Strategy Group (ESG) titled “ Operationalizing Encryption and Key Management .” Among the findings: lack of encryption is the primary contributor to sensitive data loss, even though confidence in cryptographic capabilities is strong.

Key Points: 
  • Fortanix® Inc. , a leader in data security and pioneer of Confidential Computing , today revealed the results of a new study conducted by Enterprise Strategy Group (ESG) titled “ Operationalizing Encryption and Key Management .” Among the findings: lack of encryption is the primary contributor to sensitive data loss, even though confidence in cryptographic capabilities is strong.
  • At the same time, encryption is pervasive and on the rise for data at rest, in motion, and in use.
  • Similarly, a lack of encryption remained the top reason for data loss for almost 33% of the respondents, and 25% experienced data loss due to policy violations such as small key size.
  • Key management systems, data loss prevention, and hardware security modules are the top three security technologies used by respondents to secure their organization's data.

Announcing Fortanix Key Insight – An Industry-First Solution to Discover and Remediate Data Security Risks in Hybrid Multicloud Environments

Retrieved on: 
Monday, November 27, 2023
Software, Networks, Internet, Data Management, Technology, Apps, Applications, Mobile, Wireless, Security, Cloud, PCI, Policy, Confidentiality, Privacy, GDPR, Risk, Multimedia, Booth, DSM, Digital Remedy, CSP, AI, NIST, AWS, Risk management, Online shopping, Cryptocurrency, Medical device

Fortanix® Inc. , a leader in data security and pioneer of Confidential Computing , today announced Key Insight, a new industry-first capability in the Fortanix Data Security Manager TM (DSM) platform designed to help enterprises discover, assess, and remediate risk and compliance gaps across hybrid multicloud environments.

Key Points: 
  • Fortanix® Inc. , a leader in data security and pioneer of Confidential Computing , today announced Key Insight, a new industry-first capability in the Fortanix Data Security Manager TM (DSM) platform designed to help enterprises discover, assess, and remediate risk and compliance gaps across hybrid multicloud environments.
  • Key Insight expands the power of Fortanix DSM, a unified data security platform for enterprise key management, data tokenization, secrets management, and more.
  • "Data encryption is crucial for protecting data, but equally crucial is the ability to pinpoint blind spots and remediate risks and compliance gaps.
  • It is in this regard that the introduction of Fortanix Key Insight can be of great help to our customers in their quest for multicloud data security and compliance."

The European Patent Office (EPO) Rules in Favor of Mara and AO3 on Validity of DSM Patent EP3530740

Retrieved on: 
Monday, November 27, 2023
Vitamins, Supplements, Manufacturing, Other Manufacturing, Health, Fitness & Nutrition, European Patent Convention, EPO, European Patent Office, DSM, AO3, DHA, Patent, Dietary supplement

Mara Renewables Corporation, and its manufacturing partner Algal Omega-3 (AO3) announced today that the European Patent Office (EPO), Opposition Division, has ruled in favor of Mara regarding the validity of DSM’s patent EP3530740, titled “Thraustochytrids, fatty acid compositions, and methods of making and uses thereof.”

Key Points: 
  • Mara Renewables Corporation, and its manufacturing partner Algal Omega-3 (AO3) announced today that the European Patent Office (EPO), Opposition Division, has ruled in favor of Mara regarding the validity of DSM’s patent EP3530740, titled “Thraustochytrids, fatty acid compositions, and methods of making and uses thereof.”
    The EPO panel decided the DSM patent as granted is not valid and that its scope must be significantly narrowed.
  • As a result, the microbial oils claimed by the patent are now limited to those containing at least 60% DHA in the triglyceride fraction, up from a previous limit of at least 50% DHA.
  • “We are pleased with the decision of the EPO opposition division.
  • We will also look to enforce our own intellectual property in a responsible manner.